- Home
- MDGL vs CHWY Comparison
MDGL vs CHWY Comparison
Compare MDGL & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | CHWY |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 11.0B |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MDGL | CHWY |
|---|---|---|
| Price | $442.20 | $24.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 23 |
| Target Price | ★ $674.45 | $44.82 |
| AVG Volume (30 Days) | 320.8K | ★ 7.0M |
| Earning Date | 04-30-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 41.32 | ★ 911.11 |
| EPS | N/A | ★ 0.43 |
| Revenue | $180,133,000.00 | ★ $11,861,335,000.00 |
| Revenue This Year | $58.70 | $8.37 |
| Revenue Next Year | $46.88 | $8.28 |
| P/E Ratio | ★ N/A | $56.72 |
| Revenue Growth | N/A | ★ 6.40 |
| 52 Week Low | $265.00 | $23.06 |
| 52 Week High | $615.00 | $48.62 |
Technical Indicators
Market Signals| Indicator | MDGL | CHWY |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 38.83 |
| Support Level | $416.43 | $23.06 |
| Resistance Level | $446.51 | $34.72 |
| Average True Range (ATR) | 15.54 | 1.06 |
| MACD | 3.66 | 0.04 |
| Stochastic Oscillator | 67.00 | 1.36 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About CHWY Chewy Inc.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.